Literature DB >> 23603894

Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma.

Qiao Qiao1, Yuanjun Jiang, Guang Li.   

Abstract

The phosphatidylinositol-3-kinase (PI3K) / protein kinase B (AKT) signal transduction pathway is commonly misregulated in lymphoma and associated with tumorigenesis and enhanced resistance to radiotherapy. Curcumin has been shown to inhibit the PI3K/AKT signal transduction pathway in several tumor models. In this study, we found that curcumin inhibits constitutive and radiation-induced expression of the PI3K/AKT pathway and its downstream regulator nuclear factor kappaB (NF-κB) in human Burkitt's lymphoma, a high-grade non-Hodgkin's lymphoma (NHL). We further demonstrated that the blockage of radiation-induced activation of the PI3K/AKT pathway and its downstream regulator NF-κB by either curcumin or specific PI3/AKT inhibitors (LY294002 for PI3K or SH-5 for AKT) enhance apoptosis in three human Burkitt's lymphoma cell lines (Namalwa, Ramos, and Raji) that were treated with ionizing radiation. However, no synergic effect on radiation-induced apoptosis was found in the cells co-pretreated with curcumin combined with LY294002 or curcumin combined with SH-5. The results from this study suggest that curcumin might play an important role in radiotherapy of high-grade NHL through inhibition of the PI3K/AKT-dependent NF-κB pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603894     DOI: 10.1254/jphs.12149fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  31 in total

1.  Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.

Authors:  Jin Chen; Feng-Ling Wang; Wei-Dong Chen
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

2.  miR-590-3p mediates the protective effect of curcumin on injured endothelial cells induced by angiotensin II.

Authors:  Tian Wu; Yuanyuan Xiang; Yu Lv; Dai Li; Lijin Yu; Ren Guo
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 3.  Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing.

Authors:  Muobarak Jaber Tuorkey
Journal:  Interv Med Appl Sci       Date:  2014-12-22

4.  Cytotoxic, chemosensitizing and radiosensitizing effects of curcumin based on thioredoxin system inhibition in breast cancer cells: 2D vs. 3D cell culture system.

Authors:  Shaymaa Essam El Feky; Magda Abdel Ghany Megahed; Nadia Ahmed Abd El Moneim; Ebtsam Rizq Zaher; Shadwa Ahmed Khamis; Lamiaa Mohamed Ahmed Ali
Journal:  Exp Ther Med       Date:  2021-03-18       Impact factor: 2.447

5.  Development and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells.

Authors:  Singkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Chad Pickens; Cory Berkland; Songyot Anuchapreeda
Journal:  J Pharm Sci       Date:  2016-10-14       Impact factor: 3.534

Review 6.  Molecular targets of curcumin for cancer therapy: an updated review.

Authors:  Pandima Devi Kasi; Rajavel Tamilselvam; Krystyna Skalicka-Woźniak; Seyed Fazel Nabavi; Maria Daglia; Anupam Bishayee; Hamidreza Pazoki-Toroudi; Seyed Mohammad Nabavi
Journal:  Tumour Biol       Date:  2016-07-28

Review 7.  Relationship and interactions of curcumin with radiation therapy.

Authors:  Vivek Verma
Journal:  World J Clin Oncol       Date:  2016-06-10

Review 8.  Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.

Authors:  Nicholas R Galloway; Kathryn F Ball; TessaRae Stiff; Nathan R Wall
Journal:  Crit Rev Oncog       Date:  2017

9.  Low molecular weight-PAHs induced inflammation in A549 cells by activating PI3K/AKT and NF-κB signaling pathways.

Authors:  Huizhen Guo; Yushan Huang; Huiling Wang; Zhewen Zhang; Chengyun Li; Fengjing Hu; Wenwen Zhang; Yang Liu; Yong Zeng; Junling Wang
Journal:  Toxicol Res (Camb)       Date:  2021-01-25       Impact factor: 3.524

10.  Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy.

Authors:  Zhuoran Zhang; Xingli Zhao; Dongfang Wang; Dayson Moreira; Yu-Lin Su; Marice Alcantara; Piotr Swiderski; Jeffrey Wong; Susanta Hui; Stephen Forman; Larry Kwak; Marcin Kortylewski
Journal:  Mol Ther       Date:  2020-11-26       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.